Clinical Trials Directory

Trials / Unknown

UnknownNCT00318604

Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

Status
Unknown
Phase
Study type
Observational
Enrollment
Sponsor
Far Eastern Memorial Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.

Conditions

Timeline

First posted
2006-04-27
Last updated
2006-05-12

Source: ClinicalTrials.gov record NCT00318604. Inclusion in this directory is not an endorsement.